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smearwas obtained at 12 weeks gestationwhich again showed atypical
endocervical cells favoring neoplastic changes, which were concerning
for adenocarcinoma. Screening for high risk HPV was negative, and no
lesion was visible on colposcopy. Despite the usual recommendation
against endocervical curettage (ECC) during pregnancy, this procedure
was cautiously done at 15 weeks gestation,ﬁnding onlymucous and in-
ﬂammatory cells, but no identiﬁable epithelium.
Cervical conization was recommended, but was declined by the pa-
tient. Magnetic resonance imaging was performed, with no signs ofIntroduction
Clear cell adenocarcinoma of the uterine cervix is a rare tumor ac-
counting for only 4% of adenocarcinoma of the cervix (Hiroyuki et al.,
2003). Cervical cancer is the most common gynecologic malignancy
encountered in pregnancy. Overall, up to 3% of cervical cancers are di-
agnosed during a pregnancy (Nguyen et al., 2000). Despite the rela-
tive frequency of cervical cancer in pregnancy, there has been a
dearth of prospective trials to determine the proper management of
this circumstance, and we have found only one published report of
clear cell carcinoma in pregnancy. It is a common practice to delay di-
agnostic surgery until the second trimester, and where possible, to
delay deﬁnitive treatment until maturity of the infant.
Case
A healthy, 18 year-old G2P0010 presented at 6 weeks gestation
for her initial prenatal visit. Routine screening for HIV and other sex-
ually transmitted infections was negative. She had no prior Pap
smears. A screening Pap smear was performedwhich showed atypical
glandular cells (AGC) suspicious for neoplasia, and a diagnosis ofrmington, CT 06030-2947, USA.
on).
Inc.Open access under CC BY license.cervical mass, parametrial disease, or lymphadenopathy. The patient
declined further evaluation until 31 weeks gestation, when she had a
directed biopsy of a clinically suspicious lesion. Pathology showed ade-
nocarcinoma in situ, but was again concerning for invasive adenocarci-
noma. An ECC also showed atypical glandularmaterial. Her obstetrician
then performed a LEEP biopsy at 33.3 weeks gestation, which revealed
clear cell carcinoma of the cervix. Depth of invasionwas documented to
be 2 mm, but the endocervical margin was involved (see Figs. 1 and 2).
Therewas no evidence of lymphovascular invasion. The LEEP procedure
was complicated by premature rupture ofmembranes. At this point, the
patient agreed to consultation with both gynecologic oncology andma-
ternal fetal medicine. After corticosteroid administration for fetal lung
maturity, a decision was made to perform a low transverse Cesarean
section at 34 weeks gestation. Following delivery of a live infant, a rad-
ical hysterectomy with pelvic and para-aortic lymph node dissection,
and bilateral oophoropexy was performed. The ﬁnal pathology showed
clear cell adenocarcinoma, stage IB (pT1b1, pN0, cM0). Tumor depth in
the hysterectomy specimen was approximately 2 millimeters and
tumor breadth approximately 5–6 millimeters. There was no evidence
of metastasis to the lymph nodes or of lymphovascular invasion. The
patient did not receive adjuvant therapy following hysterectomy.
Internal examinations and Pap smears of the vaginal cuff have
been done at regular intervals for the ensuing three years, and have
remained normal.Discussion
Recent guidelines of the American Society for Colposcopy and Cervical
Pathology (ASCCP) have stressed that women should not receive Pap
cytology testing until age 21 (Saslow et al., 2012). The expressed concern
is that abnormal Pap cytology ﬁndings in younger women will lead to
Fig. 1. Low power view (20×) of cervical lesion with clear illustration of positive
endocervical margin.
50 E. Ashton et al. / Gynecologic Oncology Reports 5 (2013) 49–51unnecessary interventions and an increased risk of pregnancy complica-
tions. They present data to show a high probability that many lesions in
young women would have regressed spontaneously, or are usually
“many years from having signiﬁcant potential for becoming cancer”
(Saslow et al., 2012). They refer to the increased risk of pregnancy
complications and preterm delivery, and speculate that the net
harm probably exceeds the beneﬁt.
The ASCCP recommendation does not use the age of sexual debut as a
criterion for when to begin cytologic screening, though they do note that
increased screeningmay be needed in immunocompromised or HIV pos-
itive patients. Neither of these factorswould have applied to the patient in
this report. Other authors have expressed the opinion that some popula-
tions of young womenmight beneﬁt from early screening. In an observa-
tional study on adolescents who were referred to a colposcopy clinic in
the United Kingdom over a 10 year period, Saleh et al. (2007 Nov) recog-
nized an increased incidence of moderate or severe dyskaryosis in those
whose ﬁrst sexual contact was before the age of 16, and in those withFig. 2. High power view (200×) of positive margin from the LEEP specimen. Slides sub-
mitted by Seema Khutti, MD.multiple sexual partners. These authors concluded that younger women
should remain in the screening population.
Our case preceded the current ASCCP guidelines, and it is interesting
to speculate on the differences in outcome that the newguidelinesmight
have engendered. Without an early pregnancy Pap smear, we would
probably not have detected this asymptomatic, early adenocarcinoma
prior to delivery. She would not have had the LEEP conization at
33 weeks, with the ensuing premature rupture of the membranes and
subsequent pre-termdelivery. Perhaps her cancerwouldhave beenvisu-
ally detected on a post-partum exam, or clinically suspected from symp-
toms. A conization at that time could have been sufﬁciently radical to
allow complete assessment of her cervix. This would have averted the
necessity to choose a surgical procedure before we had complete infor-
mation about her cancer. Conversely, it is possible that her cancer
would not have been found post-partum or might have progressed
quickly given the more aggressive clear cell histology. In that case, she
might have faced the hazards of a more advanced cervical cancer. Our
case illustrates both the potential harms and the potential beneﬁts that
were considered by the ASCCP prior to their recommendation on the
age at which screening begins. In balance we ﬁnd that it is not possible
to fully endorse the management of this case. LEEP conization at
33.3 weeks led directly to an early delivery and the shallow nature of
this specimen prevented an adequate understanding of her pathology.
If the size of her lesion had been fully evaluated, this would have poten-
tially allowed consideration of fertility sparing surgery.
Dargent et al. (1994)ﬁrst described “fertility sparing” trachelectomy
for womenwith cervical cancers less than 2 cm. Radical vaginal, laparo-
scopic, and abdominal trachelectomy with laparoscopic lymph node
dissection have all been reported. At the time of this patient's presenta-
tion, the literature to support fertility sparing trachelectomy was still
limited; with Abu-Rustum reporting on 42 patients and Plante on 72
patients (Abu-Rustum et al., 2006; Plante et al., 2005). The majority of
patients in both of these studies had squamous cell carcinoma and
there was no speciﬁc experience with clear cell carcinoma. Shortly
after this patient's delivery, Ramirez et al. (2008) reported on 520 pa-
tients who had radical trachelectomy, and found a 50% rate of term
birth among those patients who attempted pregnancy.
Since that time, however, there has been signiﬁcant increase in the
literature supportive of both the oncologic safety and reproductive
outcomes of fertility sparing treatment. Even in their updated series,
Plante in 2011 and Abu-Rustum in 2012 with a combined total of
245 patients included no cases of clear cell carcinoma (Plante et al.,
2011; Kim et al., 2012).
Lack of data regarding the safety of conservative management
with the more aggressive clear cell histology along with uncertainty
as to the extent of disease led us to favor radical hysterectomy rather
than conservative management in our patient. The outcomes for both
the mother and baby have remained excellent. The subsequently pub-
lished data regarding the safety of extending the applications of fertil-
ity sparing surgery, and the policy change brought about by the
recommendation of the ASCCP to stop Pap screening in teenage girls
both suggest that it is important to consider alternative methods of
managing early cervical cancer in future pregnant patients.
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